Evaluation of Antibody and T Cell Immunıty Response In Different Immunization Groups of Inactive and mRNA COVID-19 Vaccines

A RCT Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac

(2022) Chris Ka Pun Mok et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The T cell immune response against SARS-CoV-2

(2022) Paul Moss   NATURE IMMUNOLOGY

Neutralizing antibodies against the SARS-CoV-2 Omicron variant following homologous and heterologous CoronaVac or BNT162b2 vaccination

(2022) Samuel M. S. Cheng et al.   NATURE MEDICINE

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination

(2022) Eddy Pérez-Then et al.   NATURE MEDICINE

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant

(2022) Fanglei Zuo et al.   Nature Communications

Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac

(2022) Ferda Özyurda et al.   MIKROBIYOLOJI BULTENI

Humoral immune response characterization of heterologous prime-boost vaccination with CoronaVac and BNT162b2

(2022) Florencia Rammauro et al.   VACCINE

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

(2021) Nicole Doria-Rose et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quantitation of antibodies against SARS‐CoV‐2 spike protein after two doses of CoronaVac in healthcare workers

(2021) Ayşen Bayram et al.   JOURNAL OF MEDICAL VIROLOGY

Factors Affecting Side Effects, Seroconversion Rates and Antibody Response After Inactivated SARS-CoV-2 Vaccination in Healthcare Workers

(2021) Şebnem Şenol Akar et al.   MIKROBIYOLOJI BULTENI

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong

(2021) Chris Ka Pun Mok et al.   RESPIROLOGY

Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection

(2021) Harika Oyku Dinc et al.   VACCINE

Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis

(2021) Yifei Ma et al.   Journal for ImmunoTherapy of Cancer

Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants

(2021) Rüdiger Groß et al.   EBioMedicine

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

(2020) Wanbo Tai et al.   Cellular & Molecular Immunology

Immunology of COVID-19: current state of the science

(2020) Nicolas Vabret et al.   IMMUNITY

Sex differences in immune responses that underlie COVID-19 disease outcomes

(2020) Takehiro Takahashi et al.   NATURE

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

(2020) Yanchun Peng et al.   NATURE IMMUNOLOGY

What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses

(2020) Nirupa Gadi et al.   Frontiers in Immunology

Correlates of protection against SARS-CoV-2 in rhesus macaques

(2020) Katherine McMahan et al.   NATURE

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

(2020) Alicia T. Widge et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diversification of IgG effector functions

(2017) Stylianos Bournazos et al.   INTERNATIONAL IMMUNOLOGY